Robby Engelmann

916 total citations
35 papers, 663 citations indexed

About

Robby Engelmann is a scholar working on Rheumatology, Surgery and Oncology. According to data from OpenAlex, Robby Engelmann has authored 35 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 7 papers in Surgery and 7 papers in Oncology. Recurrent topics in Robby Engelmann's work include Rheumatoid Arthritis Research and Therapies (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Oral microbiology and periodontitis research (4 papers). Robby Engelmann is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Oral microbiology and periodontitis research (4 papers). Robby Engelmann collaborates with scholars based in Germany, Austria and United States. Robby Engelmann's co-authors include Brigitte Müller‐Hilke, Hermann Lang, Martin Eggert, Gunther Neeck, Bernd Kreikemeyer, Andreas Krause, J. Brandt, Kirsten Karberg, Michael Jonas and Carsten Perka and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Robby Engelmann

34 papers receiving 648 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robby Engelmann Germany 15 189 148 131 119 105 35 663
Octavio Aravena Chile 14 487 2.6× 142 1.0× 110 0.8× 53 0.4× 117 1.1× 22 860
Cor L. Verweij Netherlands 12 476 2.5× 233 1.6× 138 1.1× 76 0.6× 115 1.1× 17 1.0k
Julio Granados Mexico 14 184 1.0× 135 0.9× 84 0.6× 112 0.9× 30 0.3× 36 651
Laëtitia Le Pottier France 17 440 2.3× 169 1.1× 105 0.8× 131 1.1× 84 0.8× 33 893
Jehan Alam United States 16 137 0.7× 165 1.1× 147 1.1× 46 0.4× 117 1.1× 27 807
Tsuyoshi Kobashigawa Japan 14 378 2.0× 340 2.3× 311 2.4× 45 0.4× 206 2.0× 39 855
Tom J. Stoof Netherlands 13 428 2.3× 121 0.8× 85 0.6× 87 0.7× 208 2.0× 19 830
Lara A. Aqrawi Norway 16 175 0.9× 145 1.0× 197 1.5× 150 1.3× 70 0.7× 26 818
Akinori Kusumi Japan 15 459 2.4× 113 0.8× 134 1.0× 69 0.6× 99 0.9× 20 904
Nooshin K. Brinster United States 15 535 2.8× 178 1.2× 130 1.0× 99 0.8× 156 1.5× 74 1.6k

Countries citing papers authored by Robby Engelmann

Since Specialization
Citations

This map shows the geographic impact of Robby Engelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robby Engelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robby Engelmann more than expected).

Fields of papers citing papers by Robby Engelmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robby Engelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robby Engelmann. The network helps show where Robby Engelmann may publish in the future.

Co-authorship network of co-authors of Robby Engelmann

This figure shows the co-authorship network connecting the top 25 collaborators of Robby Engelmann. A scholar is included among the top collaborators of Robby Engelmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robby Engelmann. Robby Engelmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Engelmann, Robby & Sebastian Böttcher. (2024). Flow Cytometric MRD Detection in Selected Mature B-Cell Malignancies. Methods in molecular biology. 2865. 145–188. 1 indexed citations
2.
Engelmann, Robby, Nadja Jaekel, Frank Bernhard Kraus, et al.. (2023). Vector-based SARS-CoV-2 vaccination is associated with improved T-cell responses in hematological neoplasia. Blood Advances. 7(14). 3403–3415. 1 indexed citations
4.
Böttcher, Sebastian, Robby Engelmann, Georgiana Grigore, et al.. (2021). Expert-independent classification of mature B-cell neoplasms using standardized flow cytometry: a multicentric study. Blood Advances. 6(3). 976–992. 14 indexed citations
5.
Engelmann, Robby, et al.. (2019). Human adipocytes and CD34+ cells from the stromal vascular fraction of the same adipose tissue differ in their energy metabolic enzyme configuration. Experimental Cell Research. 380(1). 47–54. 3 indexed citations
6.
Engelmann, Robby, et al.. (2019). A novel method to efficiently isolate medullary thymic epithelial cells from murine thymi based on UEA-1 MicroBeads. Journal of Immunological Methods. 467. 12–18. 1 indexed citations
8.
Engelmann, Robby, et al.. (2018). <b><i>Porphyromonas gingivalis</i></b> Peptidyl Arginine Deiminase Can Modulate Neutrophil Activity via Infection of Human Dental Stem Cells. Journal of Innate Immunity. 10(4). 264–278. 8 indexed citations
9.
Kirschstein, Timo, et al.. (2017). Mycophenolate mofetil prevents the delayed T cell response after pilocarpine-induced status epilepticus in mice. PLoS ONE. 12(11). e0187330–e0187330. 11 indexed citations
10.
11.
Engelmann, Robby, et al.. (2016). Human dental stem cells suppress PMN activity after infection with the periodontopathogens Prevotella intermedia and Tannerella forsythia. Scientific Reports. 6(1). 39096–39096. 20 indexed citations
12.
Engelmann, Robby, et al.. (2016). The Prerequisites for Central Tolerance Induction against Citrullinated Proteins in the Mouse. PLoS ONE. 11(6). e0158773–e0158773. 8 indexed citations
13.
Engelmann, Robby, Ni Wang, C. Kneitz, & Brigitte Müller‐Hilke. (2014). Bone resorption correlates with the frequency of CD5+ B cells in the blood of patients with rheumatoid arthritis. Lara D. Veeken. 54(3). 545–553. 7 indexed citations
14.
Sombetzki, Martina, Claudia Fuchs, Peter Fickert, et al.. (2014). 24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis. Journal of Hepatology. 62(4). 871–878. 53 indexed citations
15.
Engelmann, Robby, Johannes Keller, Sarah Joost, et al.. (2012). High bone mass in the STR/ort mouse results from increased bone formation and impaired bone resorption and is associated with extramedullary hematopoiesis. Journal of Bone and Mineral Metabolism. 31(1). 71–81. 19 indexed citations
16.
Engelmann, Robby, et al.. (2010). The impact of HLA-DRB alleles on the subclass titres of antibodies against citrullinated peptides. Lara D. Veeken. 49(10). 1862–1866. 11 indexed citations
17.
Engelmann, Robby, J. Brandt, Martin Eggert, et al.. (2009). The Anti-mutated Citrullinated Vimentin Response Classifies Patients with Rheumatoid Arthritis into Broad and Narrow Responders. The Journal of Rheumatology. 36(12). 2670–2674. 14 indexed citations
18.
Engelmann, Robby & Brigitte Müller‐Hilke. (2009). Antikörper gegen citrullinierte Peptidantigene in Klinik und Forschung. Zeitschrift für Rheumatologie. 68(6). 485–490. 1 indexed citations
19.
Hecker, Michael, Robert Goertsches, Robby Engelmann, Hans‐Juergen Thiesen, & Reinhard Guthke. (2009). Integrative modeling of transcriptional regulation in response to antirheumatic therapy. BMC Bioinformatics. 10(1). 262–262. 32 indexed citations
20.
Raunest, J., Robby Engelmann, Michael Jonas, & E. Derra. (2001). Morbidität und Letalität bei hüftgelenknahen Femurfrakturen im höheren Lebensalter. Der Unfallchirurg. 104(4). 325–332. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026